Key result
The combination of the VDN aging model and myocardial infarction significantly reduced ejection fraction, stroke volume, and cardiac output compared to all other groups (P<0.05).
Why the study?
Does the combination of an aging vascular model (VDN) and myocardial infarction alter cardiac function in Wistar rats?
Does the combination of an aging vascular model (VDN) and myocardial infarction alter cardiac function in Wistar rats?
p-value: p=<0.05
The combination of an aging vascular model (VDN) and myocardial infarction in rats leads to significant deterioration in cardiac function, providing a model for studying cardiovascular aging and novel therapies.
No takes yet. Share an insight, caveat, or question.
Supports preclinical study of vascular aging plus MI interactions; hypothesis-generating and should not change clinical practice.
Jegger et al. (2007) studied Isolated systolic hypertension and myocardial infarction (n=43). Vitamin D(3) and nicotine (VDN) treatment and/or myocardial infarction vs. Sham-treated control was evaluated on Cardiac function and structural alterations (including ejection fraction, stroke volume, and cardiac output) (p=<0.05). The combination of the VDN aging model and myocardial infarction significantly reduced ejection fraction, stroke volume, and cardiac output compared to all other groups (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: